Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 434 articles:
HTML format



Single Articles


    March 2024
  1. GOLPARIAN D, Bazzo ML, Ahlstrand J, Schorner MA, et al
    Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
    J Antimicrob Chemother. 2024 Mar 22:dkae075. doi: 10.1093.
    PubMed     Abstract available


  2. PITT-KENDALL R, Sun S, Hughes S, Merrick R, et al
    Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016-20.
    J Antimicrob Chemother. 2024 Mar 22:dkae073. doi: 10.1093.
    PubMed     Abstract available


  3. PHILIP A, Oueslati S, Villa F, Pannetier C, et al
    Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
    J Antimicrob Chemother. 2024 Mar 19:dkae062. doi: 10.1093.
    PubMed     Abstract available


  4. KITTL S, Brodard I, Tresch M, Perreten V, et al
    Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid.
    J Antimicrob Chemother. 2024 Mar 18:dkae066. doi: 10.1093.
    PubMed     Abstract available


  5. ANJUM MF, Duggett N, Sheldon E, Sharma M, et al
    Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter.
    J Antimicrob Chemother. 2024 Mar 5:dkae052. doi: 10.1093.
    PubMed     Abstract available


  6. REZZOUG I, Emeraud C, Girlich D, Creton E, et al
    Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France.
    J Antimicrob Chemother. 2024;79:683-685.
    PubMed    


    February 2024
  7. VAN HAL SJ, Jensen SO, Tong SYC, Bentley S, et al
    Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Feb 27:dkae048. doi: 10.1093.
    PubMed     Abstract available


  8. JACQUELINE C, Samper-Cativiela C, Monzon Fernandez S, Ugarte-Ruiz M, et al
    Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021.
    J Antimicrob Chemother. 2024 Feb 16:dkae029. doi: 10.1093.
    PubMed     Abstract available


  9. XU Y, Luo X, Yuan B, Liang P, et al
    The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study.
    J Antimicrob Chemother. 2024 Feb 15:dkae035. doi: 10.1093.
    PubMed     Abstract available


  10. HELBO T, Boel JB, Bartels MD, Ahlstrom MG, et al
    Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
    J Antimicrob Chemother. 2024 Feb 9:dkae036. doi: 10.1093.
    PubMed     Abstract available


  11. SOMAJO S, Nilsson F, Ekelund O, Unemo M, et al
    Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
    J Antimicrob Chemother. 2024 Feb 9:dkae034. doi: 10.1093.
    PubMed     Abstract available


  12. ROY S, Morita D, Bhattacharya S, Dutta S, et al
    Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India.
    J Antimicrob Chemother. 2024 Feb 9:dkae024. doi: 10.1093.
    PubMed     Abstract available


  13. MCHUGH MP, Pettigrew KA, Taori S, Evans TJ, et al
    Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 2024 Feb 7:dkae023. doi: 10.1093.
    PubMed     Abstract available


  14. AULICINO PC, Sharma S, Truong K, Kukunoor V, et al
    Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy.
    J Antimicrob Chemother. 2024;79:370-374.
    PubMed     Abstract available


  15. HU EW, Lu HF, Lin YT, Yang TC, et al
    Modulatory role of SmeQ in SmeYZ efflux pump-involved functions in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2024;79:383-390.
    PubMed     Abstract available


  16. NDUVA GM, Otieno F, Kimani J, Sein Y, et al
    Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
    J Antimicrob Chemother. 2024;79:287-296.
    PubMed     Abstract available


  17. FERRARIS L, Delannoy J, Mazuet C, Diancourt L, et al
    Clostridium neonatale antimicrobial susceptibility, genetic resistance determinants, and genotyping: a multicentre spatiotemporal retrospective analysis.
    J Antimicrob Chemother. 2024;79:271-279.
    PubMed     Abstract available


  18. HOSAKA Y, Muraki Y, Kajihara T, Kawakami S, et al
    Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
    J Antimicrob Chemother. 2024;79:312-319.
    PubMed     Abstract available


    January 2024
  19. FINDLAY J, Bianco G, Boattini M, Nordmann P, et al
    In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA.
    J Antimicrob Chemother. 2024 Jan 31:dkae018. doi: 10.1093.
    PubMed    


  20. WASAN H, Reeta KH, Gupta YK
    Strategies to improve antibiotic access and a way forward for lower middle-income countries.
    J Antimicrob Chemother. 2024;79:1-10.
    PubMed     Abstract available


  21. RITCHIE G, Chorlton SD, Matic N, Bilawka J, et al
    WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
    J Antimicrob Chemother. 2024;79:55-60.
    PubMed     Abstract available


  22. QI Q, Ghaly TM, Rajabal V, Gillings MR, et al
    Dissecting molecular evolution of class 1 integron gene cassettes and identifying their bacterial hosts in suburban creeks via epicPCR.
    J Antimicrob Chemother. 2024;79:100-111.
    PubMed     Abstract available


    December 2023
  23. GILL CM, Santini D, Nicolau DP
    In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
    J Antimicrob Chemother. 2023 Dec 28:dkad396. doi: 10.1093.
    PubMed     Abstract available


  24. XU C, Li Y, Li Y, Huang L, et al
    Characterization of an ST38 carbapenem-resistant and highly virulent Escherichia coli carrying conjugatively transferable ColV virulence-resistance and blaNDM-5-positive resistance plasmids.
    J Antimicrob Chemother. 2023 Dec 28:dkad403. doi: 10.1093.
    PubMed     Abstract available


  25. MASSACCI FR, Cucco L, Paniccia M, Luppi A, et al
    Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin.
    J Antimicrob Chemother. 2023 Dec 28:dkad395. doi: 10.1093.
    PubMed     Abstract available


  26. ZHAO M, He S, Wen R, Li C, et al
    Membrane vesicles derived from Enterococcus faecalis promote the co-transfer of important antibiotic resistance genes located on both plasmids and chromosomes.
    J Antimicrob Chemother. 2023 Dec 18:dkad381. doi: 10.1093.
    PubMed     Abstract available


  27. ERTL NG, Anderson TK, Pardo CJ, Maidment TI, et al
    Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
    J Antimicrob Chemother. 2023 Dec 15:dkad373. doi: 10.1093.
    PubMed    


  28. SHENG Q, Wang N, Zhou Y, Deng X, et al
    A new function of thymol nanoemulsion for reversing colistin resistance in Salmonella enterica serovar Typhimurium infection.
    J Antimicrob Chemother. 2023;78:2983-2994.
    PubMed     Abstract available


  29. DJIYOU ABD, Penda CI, Madec Y, Ngondi GD, et al
    Prevalence of HIV drug resistance among adolescents receiving ART in Cameroon with low- or high-level viraemia.
    J Antimicrob Chemother. 2023;78:2938-2942.
    PubMed     Abstract available


  30. UNO S, Gatanaga H, Hayashida T, Imahashi M, et al
    Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective study.
    J Antimicrob Chemother. 2023;78:2859-2868.
    PubMed     Abstract available


  31. MACGOWAN AP, Attwood MLG, Noel AR, Barber R, et al
    Exposure of Escherichia coli to antibiotic-efflux pump inhibitor combinations in a pharmacokinetic model: impact on bacterial clearance and drug resistance.
    J Antimicrob Chemother. 2023;78:2869-2877.
    PubMed     Abstract available


    November 2023
  32. JIANG N, Chen H, Cheng L, Fu Q, et al
    Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China.
    J Antimicrob Chemother. 2023 Nov 29:dkad365. doi: 10.1093.
    PubMed     Abstract available


  33. BOU-ANTOUN S, Rokadiya S, Ashiru-Oredope D, Demirjian A, et al
    COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
    J Antimicrob Chemother. 2023;78.
    PubMed     Abstract available


  34. LEFRANC M, Accoceberry I, Fitton-Ouhabi V, Biteau N, et al
    Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
    J Antimicrob Chemother. 2023 Nov 22:dkad359. doi: 10.1093.
    PubMed     Abstract available


  35. NING YT, Sun TS, Dai RC, Luo ZY, et al
    Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China.
    J Antimicrob Chemother. 2023 Nov 22:dkad356. doi: 10.1093.
    PubMed     Abstract available


  36. DAI X, Sun J, Zhao W, Wang J, et al
    Emergence of a novel ISS1N-optrA-carrying transposon within an integrative and conjugative element from Streptococcus parasuis.
    J Antimicrob Chemother. 2023 Nov 15:dkad347. doi: 10.1093.
    PubMed     Abstract available


  37. LODISE TP, Yucel E, Obi EN, Watanabe AH, et al
    Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer beta-lactam or beta-lactam/beta-lactamase inhib
    J Antimicrob Chemother. 2023 Nov 14:dkad351. doi: 10.1093.
    PubMed     Abstract available


  38. LI J, Song Y, Deng J, Wang Z, et al
    Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
    J Antimicrob Chemother. 2023 Nov 7:dkad307. doi: 10.1093.
    PubMed     Abstract available


  39. LI M, Song C, Hu J, Dong A, et al
    Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.
    J Antimicrob Chemother. 2023;78:2743-2751.
    PubMed     Abstract available


  40. FUNICIELLO E, Mula J, Mignone F, Silvestro E, et al
    Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis.
    J Antimicrob Chemother. 2023;78:2776-2778.
    PubMed    


    October 2023
  41. TRUSWELL A, Lee ZZ, Stegger M, Blinco J, et al
    Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry.
    J Antimicrob Chemother. 2023 Oct 21:dkad323. doi: 10.1093.
    PubMed     Abstract available


  42. CALADO NOGUEIRA DE MOURA V, Nguyen MH, Hunkins JJ, Daley CL, et al
    In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
    J Antimicrob Chemother. 2023 Oct 21:dkad317. doi: 10.1093.
    PubMed     Abstract available


  43. LEE SY, Gill CM, Nicolau DP
    Activity of novel beta-lactam/beta-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2023 Oct 16:dkad225. doi: 10.1093.
    PubMed     Abstract available


  44. CINTHI M, Coccitto SN, Simoni S, Zeni G, et al
    Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain.
    J Antimicrob Chemother. 2023 Oct 14:dkad321. doi: 10.1093.
    PubMed    


  45. HALLIDAY C, Kim HY, Tay E, Chen SCA, et al
    Exploring synergy between azole antifungal drugs and statins for Candida auris.
    J Antimicrob Chemother. 2023 Oct 12:dkad303. doi: 10.1093.
    PubMed     Abstract available


  46. PICCICA M, Spinicci M, Botta A, Bianco V, et al
    Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
    J Antimicrob Chemother. 2023 Oct 9:dkad298. doi: 10.1093.
    PubMed     Abstract available


  47. CHEN Y, Yong M, Li M, Si Z, et al
    A hydrophilic polyimidazolium antibiotic targeting the membranes of Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:2581-2590.
    PubMed     Abstract available


  48. MARUAPULA D, Moraka NO, Bareng OT, Mokgethi PT, et al
    Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
    J Antimicrob Chemother. 2023;78:2489-2495.
    PubMed     Abstract available


    September 2023

  49. Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
    J Antimicrob Chemother. 2023 Sep 14:dkad282. doi: 10.1093.
    PubMed    


  50. JAHA B, Schenkel CD, Jorimann L, Huber M, et al
    Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
    J Antimicrob Chemother. 2023;78:2323-2334.
    PubMed     Abstract available


  51. VAN HAL SJ, Whiley DM, Le T, Ray S, et al
    Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
    J Antimicrob Chemother. 2023;78:2203-2208.
    PubMed     Abstract available


    August 2023
  52. POWELL LM, Choi SJ, Haught BL, Demkowicz R, et al
    Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.
    J Antimicrob Chemother. 2023 Aug 28:dkad268. doi: 10.1093.
    PubMed     Abstract available


  53. ASHIRU-OREDOPE D, Cunningham N, Casale E, Muller-Pebody B, et al
    Reporting England's progress towards the ambitions in the UK action plan for antimicrobial resistance: the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR).
    J Antimicrob Chemother. 2023 Aug 19:dkad248. doi: 10.1093.
    PubMed     Abstract available


  54. LOPEZ-CUBILLOS JF, Diaz A, Cardenas VC, Camacho-Moreno G, et al
    Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study.
    J Antimicrob Chemother. 2023 Aug 16:dkad255. doi: 10.1093.
    PubMed     Abstract available


  55. GREIG DR, Do Nascimento V, Olonade I, Swift C, et al
    Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016-2020.
    J Antimicrob Chemother. 2023 Aug 7:dkad231. doi: 10.1093.
    PubMed     Abstract available


  56. KOSTOVA V, Hanke D, Schink AK, Kaspar H, et al
    ICE-borne erm(T)-mediated macrolide resistance in Mannheimia haemolytica.
    J Antimicrob Chemother. 2023 Aug 3:dkad209. doi: 10.1093.
    PubMed    


  57. ABDULLAHI A, Kida IM, Maina UA, Ibrahim AH, et al
    Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.
    J Antimicrob Chemother. 2023;78:2000-2007.
    PubMed     Abstract available


  58. CARTER C, Hutchison A, Rudder S, Trotter E, et al
    Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK.
    J Antimicrob Chemother. 2023;78:2028-2036.
    PubMed     Abstract available


  59. LAI H, Li R, Li Z, Zhang B, et al
    Modelling the impact of treatment adherence on the transmission of HIV drug resistance.
    J Antimicrob Chemother. 2023;78:1934-1943.
    PubMed     Abstract available


  60. BRENNER BG, Oliveira M, Ibanescu RI, Routy JP, et al
    Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure.
    J Antimicrob Chemother. 2023;78:1921-1928.
    PubMed     Abstract available


  61. SAATHOFF M, Tedin K, Gratz S, Schwerk P, et al
    Albicidin independency of multidrug efflux systems in Salmonella enterica serovar Typhimurium.
    J Antimicrob Chemother. 2023;78:2102-2104.
    PubMed    


  62. HERSHKO Y, Levytskyi K, Rannon E, Assous MV, et al
    Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
    J Antimicrob Chemother. 2023 Aug 1:dkad236. doi: 10.1093.
    PubMed     Abstract available


    July 2023
  63. FOUAD A, Gill CM, Simner PJ, Nicolau DP, et al
    Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
    J Antimicrob Chemother. 2023 Jul 31:dkad229. doi: 10.1093.
    PubMed     Abstract available


  64. HALLAL FERREIRA RARO O, Poirel L, Tocco M, Nordmann P, et al
    Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer.
    J Antimicrob Chemother. 2023 Jul 24:dkad226. doi: 10.1093.
    PubMed     Abstract available


  65. BENDER JK, Baufeld E, Becker K, Claus H, et al
    CHROMAgar LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.
    J Antimicrob Chemother. 2023 Jul 20:dkad218. doi: 10.1093.
    PubMed     Abstract available


  66. CAI W, Lu M, Dai W
    Novel antibiotic susceptibility of an RNA polymerase alpha-subunit mutant in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2023 Jul 10:dkad207. doi: 10.1093.
    PubMed     Abstract available


  67. ZHANG D, Han J, Li H, Zheng C, et al
    Increased prevalence and stable clustering rate of HIV-1 transmitted drug resistance strains after 'treat-all' in a megacity of China.
    J Antimicrob Chemother. 2023;78:1795-1799.
    PubMed     Abstract available


  68. DUHANT A, Kusinza B, Tantet C, Bisimwa B, et al
    HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals.
    J Antimicrob Chemother. 2023;78:1732-1739.
    PubMed     Abstract available


  69. GOLPARIAN D, Jacobsson S, Holley CL, Shafer WM, et al
    High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2023;78:1769-1778.
    PubMed     Abstract available


  70. GOMIS-FONT MA, Sastre-Femenia MA, Taltavull B, Cabot G, et al
    In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2023;78:1785-1794.
    PubMed     Abstract available


  71. URUSHIBARA N, Aung MS, Kawaguchiya M, Ohashi N, et al
    Genome analysis of an SCCmec element in ST9-MRSA from Myanmar with a unique mec gene complex and two ccr gene complexes (ccrA1B1 and ccrA5B7).
    J Antimicrob Chemother. 2023;78:1805-1806.
    PubMed    


  72. KISO M, Yamayoshi S, Kawaoka Y
    Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors.
    J Antimicrob Chemother. 2023;78:1649-1657.
    PubMed     Abstract available


  73. SALMONA M, Lascoux-Combe C, Nere ML, Rubenstein E, et al
    Transmission of S230R integrase drug resistance mutation affecting second-generation integrase inhibitors in a French primary HIV-1 infected man.
    J Antimicrob Chemother. 2023;78:1802-1803.
    PubMed    


    June 2023
  74. KIM SK, Lee JB, Lee HT, Han D, et al
    Development of antisense peptide-peptide nucleic acids against fluoroquinolone-resistant Escherichia coli.
    J Antimicrob Chemother. 2023 Jun 30:dkad203. doi: 10.1093.
    PubMed     Abstract available


  75. YANG Q, Zhu Y, Schwarz S, Zhang W, et al
    Characterization of an optrA-harbouring unconventional circularizable structure located on a novel ICESa2603 family-like integrative and conjugative element ICESsuHN38 in Streptococcus suis.
    J Antimicrob Chemother. 2023 Jun 30:dkad205. doi: 10.1093.
    PubMed     Abstract available


  76. ANDO N, Mizushima D, Takano M, Mitobe M, et al
    Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.
    J Antimicrob Chemother. 2023 Jun 28:dkad208. doi: 10.1093.
    PubMed     Abstract available


  77. DEPLANO A, Hallin M, Bustos Sierra N, Michel C, et al
    Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
    J Antimicrob Chemother. 2023 Jun 26:dkad204. doi: 10.1093.
    PubMed     Abstract available


  78. MARCHANDIN H, Anjou C, Poulen G, Freeman J, et al
    In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile.
    J Antimicrob Chemother. 2023 Jun 23:dkad194. doi: 10.1093.
    PubMed     Abstract available


  79. KAKOOZA F, Golparian D, Matoga M, Maseko V, et al
    Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
    J Antimicrob Chemother. 2023 Jun 23:dkad193. doi: 10.1093.
    PubMed     Abstract available


  80. PIROLO M, Menezes M, Damborg P, Wegener A, et al
    In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2023 Jun 9:dkad182. doi: 10.1093.
    PubMed     Abstract available


  81. SIMJEE S, Tice G
    The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
    J Antimicrob Chemother. 2023 Jun 9:dkad183. doi: 10.1093.
    PubMed     Abstract available


  82. CHEN Y, Sun L, Hong Y, Chen M, et al
    Exploring the third-generation tetracycline resistance of multidrug-resistant livestock-associated methicillin-resistant Staphylococcus aureus ST9 across healthcare settings in China.
    J Antimicrob Chemother. 2023 Jun 8:dkad174. doi: 10.1093.
    PubMed     Abstract available


  83. LEI D, Cao L, Zhong T, He QY, et al
    Residue Lys219 of CpxR is critical in the regulation of the antibiotic resistance of Escherichia coli.
    J Antimicrob Chemother. 2023 Jun 8:dkad171. doi: 10.1093.
    PubMed     Abstract available


  84. LIAO CH, Ku RH, Li LH, Wu CM, et al
    Role of yceA-cybB-yceB operon in oxidative stress tolerance, swimming motility and antibiotic susceptibility of Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2023 Jun 7:dkad179. doi: 10.1093.
    PubMed     Abstract available


  85. ARMENIA D, Santoro MM, Charpentier C, Bertoli A, et al
    Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings.
    J Antimicrob Chemother. 2023;78:1415-1422.
    PubMed     Abstract available


  86. FERRAND A, Vergalli J, Bosi C, Pantel A, et al
    Contribution of efflux and mutations in fluoroquinolone susceptibility in MDR enterobacterial isolates: a quantitative and molecular study.
    J Antimicrob Chemother. 2023;78:1532-1542.
    PubMed     Abstract available


  87. LAMBERT-NICLOT S, Abdi B, Bellet J, Fofana D, et al
    Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
    J Antimicrob Chemother. 2023;78:1510-1521.
    PubMed     Abstract available


  88. ELWITIGALA J, Rajapaksa L, Inzaule SC, Ariyaratne KAM, et al
    Prevalence of pretreatment drug resistance in persons initiating and reinitiating antiretroviral therapy in Sri Lanka: results from a national representative survey.
    J Antimicrob Chemother. 2023;78:1476-1479.
    PubMed     Abstract available


  89. CHAKRAVARTY J, Srivastva S, Kushwaha AK, Pal A, et al
    Long-term treatment outcome and mutational analysis of patients on third-line antiretroviral therapy in programmatic conditions.
    J Antimicrob Chemother. 2023;78:1480-1487.
    PubMed     Abstract available


  90. BOTELHO OM, Basso RP, Da Mota LD, Da Hora VP, et al
    Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization.
    J Antimicrob Chemother. 2023;78:1444-1453.
    PubMed     Abstract available


  91. LEANGAPICHART T, Stosic MS, Hickman RA, Lunha K, et al
    Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand.
    J Antimicrob Chemother. 2023;78:1395-1405.
    PubMed     Abstract available


  92. DATTA S
    The conundrum of bacteria-specific antibiotics.
    J Antimicrob Chemother. 2023;78:1354-1358.
    PubMed     Abstract available


    May 2023
  93. CINTHI M, Massacci FR, Coccitto SN, Albini E, et al
    Characterization of a prophage and a defective integrative conjugative element carrying the optrA gene in linezolid-resistant Streptococcus dysgalactiae subsp. equisimilis isolates from pigs, Italy.
    J Antimicrob Chemother. 2023 May 31:dkad164. doi: 10.1093.
    PubMed     Abstract available


  94. VASIKASIN V, Panuvatvanich B, Rawson TM, Holmes AH, et al
    Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
    J Antimicrob Chemother. 2023 May 30:dkad165. doi: 10.1093.
    PubMed     Abstract available


  95. SEALEY JE, Saunders R, Horspool T, Barrows MG, et al
    Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo.
    J Antimicrob Chemother. 2023 May 30:dkad148. doi: 10.1093.
    PubMed     Abstract available


  96. SHEN W, Zhang R, Cai J
    Co-occurrence of multiple plasmid-borne linezolid resistance genes-optrA, cfr, poxtA2 and cfr(D) in an Enterococcus faecalis isolate from retail meat.
    J Antimicrob Chemother. 2023 May 20:dkad142. doi: 10.1093.
    PubMed     Abstract available


  97. SANDOVAL MM, Bardach A, Rojas-Roque C, Alconada T, et al
    Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.
    J Antimicrob Chemother. 2023 May 16:dkad071. doi: 10.1093.
    PubMed     Abstract available



  98. Correction to: Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries.
    J Antimicrob Chemother. 2023 May 4:dkad141. doi: 10.1093.
    PubMed    


  99. EMERAUD C, Gonzalez C, Dortet L
    Comparison of ComASP(R) and UMIC(R) methods with the reference method for cefiderocol susceptibility testing on carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2023 May 4:dkad134. doi: 10.1093.
    PubMed    


  100. ALFORD MA, Karlowsky JA, Adam HJ, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    PubMed     Abstract available


  101. MUCCINI C, Galli L, Sampaolo M, Gianotti N, et al
    Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV.
    J Antimicrob Chemother. 2023;78:1314-1315.
    PubMed    


  102. HUNT GM, Yousif M, Levin L, Ledwaba J, et al
    Resistance is common in paediatric patients failing ART in South Africa.
    J Antimicrob Chemother. 2023;78:1160-1167.
    PubMed     Abstract available


    April 2023
  103. DANESHNIA F, Hilmioglu-Polat S, Ilkit M, Fuentes D, et al
    Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis.
    J Antimicrob Chemother. 2023 Apr 26:dkad112. doi: 10.1093.
    PubMed     Abstract available


  104. PRAPHARSAVAT R, Kittikongnapang R, Smithkittipol C, Udomrat W, et al
    Raising awareness of antimicrobial resistance: development of an 'antibiotic footprint calculator'.
    J Antimicrob Chemother. 2023 Apr 18:dkad113. doi: 10.1093.
    PubMed     Abstract available


  105. KIM SY, Seo HW, Park MS, Park CM, et al
    Exploitation of a novel adjuvant for polymyxin B against multidrug-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2023;78:923-932.
    PubMed     Abstract available


  106. JOUSSET AB, Poignon C, Yilmaz S, Bleibtreu A, et al
    Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor.
    J Antimicrob Chemother. 2023;78:1125-1127.
    PubMed    


  107. GILL CM, Santini D, Takemura M, Longshaw C, et al
    In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
    J Antimicrob Chemother. 2023;78:983-990.
    PubMed     Abstract available


  108. SIJBOM M, Buchner FL, Saadah NH, Numans ME, et al
    Trends in antibiotic selection pressure generated in primary care and their association with sentinel antimicrobial resistance patterns in Europe.
    J Antimicrob Chemother. 2023 Apr 3:dkad082. doi: 10.1093.
    PubMed     Abstract available


    March 2023
  109. DIERIKX C, Hengeveld P, Witteveen S, van Hoek A, et al
    Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands.
    J Antimicrob Chemother. 2023 Mar 30:dkad047. doi: 10.1093.
    PubMed     Abstract available


  110. WOH PY, Yeung MPS, Goggins WB
    Multiple antibiotic resistance index (MARI) of human-isolated Salmonella species: a practical bacterial antibiotic surveillance tool.
    J Antimicrob Chemother. 2023 Mar 30:dkad092. doi: 10.1093.
    PubMed     Abstract available


  111. CAREY GB, Holleck JL, Ein Alshaeba S, Jayakrishnan R, et al
    Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2023 Mar 25:dkad078. doi: 10.1093.
    PubMed     Abstract available


  112. TANAKA E, Wajima T, Nakaminami H, Uchiya KI, et al
    Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae.
    J Antimicrob Chemother. 2023 Mar 23:dkad074. doi: 10.1093.
    PubMed     Abstract available


  113. ZHU Y, Xu Q, Schwarz S, Yu S, et al
    Identification of a novel MDR plasmid co-harbouring the carbapenem resistance gene blaVIM-2 and tigecycline resistance gene cluster tmexCD1-toprJ1 in a Pseudomonas stutzeri isolate.
    J Antimicrob Chemother. 2023 Mar 15:dkad075. doi: 10.1093.
    PubMed    



  114. Correction to: QMAC-dRAST for the direct testing of antibiotic susceptibility for Enterobacterales in positive blood-culture broth: a comparison of the performances with the MicroScan system and direct disc diffusion testing methods.
    J Antimicrob Chemother. 2023 Mar 7:dkad073. doi: 10.1093.
    PubMed    


  115. HEIL EL, Claeys KC, Kline EG, Rogers TM, et al
    Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
    J Antimicrob Chemother. 2023 Mar 3:dkad042. doi: 10.1093.
    PubMed     Abstract available


  116. BALAKRISHNA S, Loosli T, Zaheri M, Frischknecht P, et al
    Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
    J Antimicrob Chemother. 2023;78:656-664.
    PubMed     Abstract available


  117. KAMORI D, Barabona G, Rugemalila J, Maokola W, et al
    Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey.
    J Antimicrob Chemother. 2023;78:779-787.
    PubMed     Abstract available


  118. ZENG X, Hinenoya A, Guan Z, Xu F, et al
    Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli.
    J Antimicrob Chemother. 2023;78:732-746.
    PubMed     Abstract available


    February 2023
  119. KANEKO H, Yanagi Y, Otake S, Sato M, et al
    The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton-Valentine leucocidin and toxic shock syndrome toxin 1 genes.
    J Antimicrob Chemother. 2023 Feb 23:dkad039. doi: 10.1093.
    PubMed     Abstract available


  120. MORENO-MINGORANCE A, Mir-Cros A, Goterris L, Rodriguez-Garrido V, et al
    Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020-21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri.
    J Antimicrob Chemother. 2023 Feb 10:dkad031. doi: 10.1093.
    PubMed     Abstract available


  121. ZHU Y, Huang Y, Zheng C, Tang J, et al
    Primary resistance to integrase inhibitors in Shenzhen.
    J Antimicrob Chemother. 2023;78:546-549.
    PubMed     Abstract available


  122. YOUENOU B, Martins Simoes P, Tristan A, Farfour E, et al
    Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains.
    J Antimicrob Chemother. 2023;78:445-449.
    PubMed     Abstract available


  123. VENTOSA-CUBILLO J, Pinzon R, Gonzalez-Alba JM, Estripeaut D, et al
    Drug resistance in children and adolescents with HIV in Panama.
    J Antimicrob Chemother. 2023;78:423-435.
    PubMed     Abstract available


  124. RAYMOND S, Jeanne N, Nicot F, Dimeglio C, et al
    HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
    J Antimicrob Chemother. 2023;78:346-353.
    PubMed     Abstract available


    January 2023
  125. WAGNER TM, Howden BP, Sundsfjord A, Hegstad K, et al
    Transiently silent acquired antimicrobial resistance: an emerging challenge in susceptibility testing.
    J Antimicrob Chemother. 2023 Jan 31:dkad024. doi: 10.1093.
    PubMed     Abstract available


  126. PINTO JIMENEZ C, Pearson M, Hennessey M, Nkereuwem E, et al
    Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs.
    J Antimicrob Chemother. 2023 Jan 26:dkac424. doi: 10.1093.
    PubMed     Abstract available


  127. GALLOIS E, Fihman V, Danjean M, Gomart C, et al
    QMAC-dRAST for the direct testing of antibiotic susceptibility for Enterobacterales in positive blood-culture broth: a comparison of the performances with the MicroScan system and direct disc diffusion testing methods.
    J Antimicrob Chemother. 2023 Jan 6:dkac441. doi: 10.1093.
    PubMed     Abstract available


    December 2022
  128. DING L, Hu F
    China's new national action plan to combat antimicrobial resistance (2022-25).
    J Antimicrob Chemother. 2022 Dec 28:dkac435. doi: 10.1093.
    PubMed    


  129. NKA AD, Bouba Y, Teto G, Semengue ENJ, et al
    Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.
    J Antimicrob Chemother. 2022;78:272-275.
    PubMed     Abstract available


  130. YANG Z, Song M, Li X, Zhang Q, et al
    Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens.
    J Antimicrob Chemother. 2022;78:263-271.
    PubMed     Abstract available


  131. ZHAO B, Han H, He K, Hou WF, et al
    Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli.
    J Antimicrob Chemother. 2022;78:216-224.
    PubMed     Abstract available


  132. ARENDRUP MC, Arikan-Akdagli S, Castanheira M, Guinea J, et al
    Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin.
    J Antimicrob Chemother. 2022;78:185-195.
    PubMed     Abstract available


  133. GOLPARIAN D, Jacobsson S, Sanchez-Buso L, Bazzo ML, et al
    GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.
    J Antimicrob Chemother. 2022;78:150-154.
    PubMed     Abstract available


  134. BLAIR JMA, Siasat P, McNeil HE, Colclough A, et al
    EnvR is a potent repressor of acrAB transcription in Salmonella.
    J Antimicrob Chemother. 2022;78:133-140.
    PubMed     Abstract available


  135. WUNDERLICH A, Xanthopoulou K, Wille J, Wohlfarth E, et al
    Carbapenem resistance in Acinetobacter pittii isolates mediated by metallo-beta-lactamases.
    J Antimicrob Chemother. 2022 Dec 20:dkac418. doi: 10.1093.
    PubMed     Abstract available


  136. WAN TW, Yeo HH, Lee TF, Huang YT, et al
    Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020.
    J Antimicrob Chemother. 2022 Dec 17:dkac414. doi: 10.1093.
    PubMed     Abstract available


  137. XUAN H, Xia L, Schwarz S, Jia H, et al
    Various mobile genetic elements carrying optrA in Enterococcus faecium and Enterococcus faecalis isolates from swine within the same farm.
    J Antimicrob Chemother. 2022 Dec 12:dkac421. doi: 10.1093.
    PubMed     Abstract available


  138. XIAO J, Huang J, Xue X, Wang C, et al
    Novel cassette chromosome recombinases CcrA8B9 catalyse the excision and integration of the staphylococcal cassette chromosome mec element.
    J Antimicrob Chemother. 2022 Dec 8:dkac410. doi: 10.1093.
    PubMed     Abstract available


    November 2022
  139. NUNES CC, Sita A, Mallmann L, Birlem GE, et al
    HIV-1 genetic diversity and transmitted drug resistance to integrase strand transfer inhibitors among recently diagnosed adults in Porto Alegre, South Brazil.
    J Antimicrob Chemother. 2022;77:3510-3514.
    PubMed     Abstract available


  140. KOCER K, Boutin S, Heeg K, Nurjadi D, et al
    The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales.
    J Antimicrob Chemother. 2022;77:3487-3495.
    PubMed     Abstract available


  141. NORDMANN P, Bouvier M, Poirel L, Sadek M, et al
    Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales.
    J Antimicrob Chemother. 2022;77:3456-3461.
    PubMed     Abstract available


  142. NTAMATUNGIRO AJ, Kagura J, Weisser M, Francis JM, et al
    Pre-treatment HIV-1 drug resistance in antiretroviral therapy-naive adults in Eastern Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:3231-3241.
    PubMed     Abstract available


  143. DE DIOS R, Gadar K, McCarthy RR
    A high-efficiency scar-free genome-editing toolkit for Acinetobacter baumannii.
    J Antimicrob Chemother. 2022;77:3390-3398.
    PubMed     Abstract available


  144. GILL CM, Nicolau DP
    Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022 Nov 22:dkac385. doi: 10.1093.
    PubMed     Abstract available


  145. CASTRO BE, Rios R, Carvajal LP, Vargas ML, et al
    Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794061. doi: 10.1093.
    PubMed     Abstract available


  146. KELENTSE N, Moyo S, Choga WT, Lechiile K, et al
    High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794066. doi: 10.1093.
    PubMed     Abstract available


    October 2022
  147. HENERICO S, Lyimo E, Makubi AN, Magesa D, et al
    Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
    J Antimicrob Chemother. 2022;77:3138-3143.
    PubMed     Abstract available


  148. SCHALKWIJK HH, Gillemot S, Reynders M, Selleslag D, et al
    Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
    J Antimicrob Chemother. 2022;77:3153-3162.
    PubMed     Abstract available


  149. DAY J, Afshar B, Rowlands RS, Umer TS, et al
    Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark.
    J Antimicrob Chemother. 2022;77:3126-3129.
    PubMed     Abstract available


  150. PITT R, Boampong D, Day M, Jensen JS, et al
    Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium.
    J Antimicrob Chemother. 2022;77:2901-2907.
    PubMed     Abstract available


  151. MORENO-MORALES J, Guardiola S, Balleste-Delpierre C, Giralt E, et al
    A new synthetic protegrin as a promising peptide with antibacterial activity against MDR Gram-negative pathogens.
    J Antimicrob Chemother. 2022;77:3077-3085.
    PubMed     Abstract available


  152. SUN RY, Guo WY, Zhang JX, Wang MG, et al
    Phylogenomic analysis of Salmonella Indiana ST17, an emerging MDR clonal group in China.
    J Antimicrob Chemother. 2022;77:2937-2945.
    PubMed     Abstract available


  153. AYFAN AKS, Macdonald J, Irwin AD, Zowawi HM, et al
    Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2022;77:2933-2936.
    PubMed     Abstract available


  154. DE JONG A, El Garch F, Hocquet D, Prenger-Berninghoff E, et al
    European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6750681. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  155. SHRESTHA R, Luterbach CL, Dai W, Komarow L, et al
    Characteristics of community-acquired carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022;77:2763-2771.
    PubMed     Abstract available


  156. GROHS P, Vilfaillot A, Zahar JR, Barbut F, et al
    Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
    J Antimicrob Chemother. 2022;77:2667-2678.
    PubMed     Abstract available


  157. BRENCIANI A, Morroni G, Schwarz S, Giovanetti E, et al
    Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
    J Antimicrob Chemother. 2022;77:2596-2621.
    PubMed     Abstract available


  158. BECKER J, Perreten V, Schupbach-Regula G, Stucki D, et al
    Associations of antimicrobial use with antimicrobial susceptibility at the calf level in bacteria isolated from the respiratory and digestive tracts of veal calves before slaughter.
    J Antimicrob Chemother. 2022;77:2859-2866.
    PubMed     Abstract available


  159. AULICINO PC, Momin Z, Rozenszajn M, Monzon A, et al
    HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H.
    J Antimicrob Chemother. 2022;77:2793-2802.
    PubMed     Abstract available


  160. HAENNI M, Boulouis HJ, Lagree AC, Drapeau A, et al
    Enterobacterales high-risk clones and plasmids spreading blaESBL/AmpC and blaOXA-48 genes within and between hospitalized dogs and their environment.
    J Antimicrob Chemother. 2022;77:2754-2762.
    PubMed     Abstract available


  161. LI J, Fan Q, Zuo J, Xue B, et al
    Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730836. doi: 10.1093.
    PubMed     Abstract available


  162. TANAKA E, Wajima T, Nakaminami H, Uchiya KI, et al
    Alternative quinolone-resistance pathway caused by simultaneous horizontal gene transfer in Haemophilus influenzae.
    J Antimicrob Chemother. 2022 Sep 19. pii: 6704850. doi: 10.1093.
    PubMed     Abstract available


  163. TORUMKUNEY D, Aktas Z, Unal S, van Hasselt J, et al
    Country data on AMR in Turkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  164. TORUMKUNEY D, Kozlov R, Sidorenko S, Kamble P, et al
    Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  165. TORUMKUNEY D, Kundu S, Vu GV, Nguyen HA, et al
    Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  166. TORUMKUNEY D, Nijhara P, Beltrame CO, Baisch EQ, et al
    Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  167. TORUMKUNEY D, Jamil B, Nizamuddin S, van Hasselt J, et al
    Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  168. TORUMKUNEY D, de la Torre C, Langfeld K, Lopez-Turrent NP, et al
    Country data on AMR in Mexico in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  169. TORUMKUNEY D, Dolgum S, van Hasselt J, Abdullah W, et al
    Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  170. TORUMKUNEY D, Poojary A, Shenoy B, Nijhara P, et al
    Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  171. TORUMKUNEY D, Behbehani N, van Hasselt J, Hamouda M, et al
    Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    J Antimicrob Chemother. 2022;77.
    PubMed     Abstract available


  172. RIGATTO MH, Ramos F, Barros A, Pedroso S, et al
    Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
    J Antimicrob Chemother. 2022 Sep 1. pii: 6681124. doi: 10.1093.
    PubMed     Abstract available


    August 2022
  173. DIAZ-GARCIA J, Gomez A, Machado M, Alcala L, et al
    Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris.
    J Antimicrob Chemother. 2022 Aug 29. pii: 6678135. doi: 10.1093.
    PubMed     Abstract available


  174. MULLALLY C, Stubbs KA, Thai VC, Anandan A, et al
    Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase.
    J Antimicrob Chemother. 2022;77:2441-2447.
    PubMed     Abstract available


  175. YANG F, Gao S, Yan J, Lin X, et al
    Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model.
    J Antimicrob Chemother. 2022;77:2461-2469.
    PubMed     Abstract available


  176. WANG G, Wu P, Tang R, Zhang W, et al
    Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2353-2363.
    PubMed     Abstract available


  177. KHOUJA T, Tadrous M, Suda KJ
    Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)-authors' response.
    J Antimicrob Chemother. 2022 Aug 18. pii: 6670898. doi: 10.1093.
    PubMed    


  178. FONG W, Timms V, Sim E, Pey K, et al
    Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667673. doi: 10.1093.
    PubMed     Abstract available


  179. NUESCH-INDERBINEN M, Biggel M, Zurfluh K, Treier A, et al
    Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667639. doi: 10.1093.
    PubMed     Abstract available


  180. MURRAY CJL
    BSAC Vanguard Series: Tracking the global rise of antimicrobial resistance.
    J Antimicrob Chemother. 2022 Aug 5. pii: 6656168. doi: 10.1093.
    PubMed     Abstract available


    July 2022
  181. ROGERS TR, Verweij PE, Castanheira M, Dannaoui E, et al
    Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
    J Antimicrob Chemother. 2022;77:2053-2073.
    PubMed     Abstract available


  182. ZHAI W, Wang T, Yang D, Zhang Q, et al
    Clonal relationship of tet(X4)-positive Escherichia coli ST761 isolates between animals and humans.
    J Antimicrob Chemother. 2022;77:2153-2157.
    PubMed     Abstract available


  183. KRUGER H, Ji X, Hanke D, Schink AK, et al
    Novel macrolide-lincosamide-streptogramin B resistance gene erm(54) in MRSA ST398 from Germany.
    J Antimicrob Chemother. 2022;77:2296-2298.
    PubMed    


  184. KIRUTHIKA S, Bhat R, Jayaram B, Vivekanandan P, et al
    A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus.
    J Antimicrob Chemother. 2022;77:2120-2124.
    PubMed     Abstract available


  185. BONCOMPAGNI SR, Micieli M, Di Maggio T, Aiezza N, et al
    Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens.
    J Antimicrob Chemother. 2022;77:2199-2208.
    PubMed     Abstract available


  186. KUFEL WD, Abouelhassan Y, Steele JM, Gutierrez RL, et al
    Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648989. doi: 10.1093.
    PubMed     Abstract available


  187. SEALEY JE, Hammond A, Mounsey O, Gould VC, et al
    Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
    J Antimicrob Chemother. 2022 Jul 20. pii: 6645196. doi: 10.1093.
    PubMed     Abstract available


  188. EMERAUD C, Godmer A, Girlich D, Vanparis O, et al
    Activity of mecillinam against carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Jul 11. pii: 6639593. doi: 10.1093.
    PubMed     Abstract available


  189. KO D, Choi SH
    Mechanistic understanding of antibiotic resistance mediated by EnvZ/OmpR two-component system in Salmonella enterica serovar Enteritidis.
    J Antimicrob Chemother. 2022 Jul 4. pii: 6628285. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  190. HACKMANN C, Gastmeier P, Schwarz S, Lubke-Becker A, et al
    Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis-authors' response.
    J Antimicrob Chemother. 2022;77:2043.
    PubMed    


  191. ROZENSZAJN M, Arazi-Caillaud S, Taicz M, Bologna R, et al
    HIV-1 pretreatment drug resistance in vertically infected children is associated with poor virological response to protease inhibitor (PI)-based first-line antiretroviral therapy (ART): results from a cohort study in Argentina.
    J Antimicrob Chemother. 2022;77:1969-1973.
    PubMed     Abstract available


  192. LAN Y, Li F, Li L, Deng X, et al
    Drug resistance and genetic transmission characteristics of HIV-1 CRF59_01B in infected patients in Guangdong Province, China.
    J Antimicrob Chemother. 2022;77:1960-1968.
    PubMed     Abstract available


  193. ENGONE-ONDO JD, Bignoumba M, Boundzanga Moussavou P, Gafou A, et al
    HIV-1 non-B resistance mutations and natural polymorphisms to integrase strand transfer inhibitors in recently diagnosed patients in Gabon, Central Africa.
    J Antimicrob Chemother. 2022;77:2035-2037.
    PubMed    


  194. TORRENS G, van der Schalk TE, Cortes-Lara S, Timbermont L, et al
    Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
    J Antimicrob Chemother. 2022;77:1862-1872.
    PubMed     Abstract available


  195. EL-QUSHAYRI AE, Ghozy S
    Comment on: Pet husbandry as a risk factor for colonization or infection with MDR organisms: a systematic meta-analysis.
    J Antimicrob Chemother. 2022;77:2042.
    PubMed    


  196. MITCHELL J, O'Neill AJ, King R
    Creating a framework to align antimicrobial resistance (AMR) research with the global guidance: a viewpoint.
    J Antimicrob Chemother. 2022 Jun 24. pii: 6617339. doi: 10.1093.
    PubMed     Abstract available


  197. GINEVRA C, Beraud L, Pionnier I, Sallabery K, et al
    Detection of highly macrolide-resistant Legionella pneumophila strains from a hotel water network using systematic whole-genome sequencing.
    J Antimicrob Chemother. 2022 Jun 9. pii: 6604636. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  198. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of an MDR Lactobacillus salivarius isolate harbouring the phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2022 May 31. pii: 6595591. doi: 10.1093.
    PubMed     Abstract available


  199. SULIS G, Pai M, Gandra S
    Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 May 31. pii: 6595593. doi: 10.1093.
    PubMed    


  200. NAHA S, Sands K, Mukherjee S, Dutta S, et al
    A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics.
    J Antimicrob Chemother. 2022;77:1586-1591.
    PubMed     Abstract available


  201. LIU P, Qin X, Cao T, Yang Y, et al
    Telithromycin resistance in Campylobacter mediated by 23S rRNA A2075G mutation and erm(B).
    J Antimicrob Chemother. 2022;77:1557-1560.
    PubMed     Abstract available


  202. REVOLLO B, Vinuela L, de la Mora L, Garcia F, et al
    Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.
    J Antimicrob Chemother. 2022;77:1738-1740.
    PubMed     Abstract available


  203. JAUNEIKAITE E, Honeyford K, Blandy O, Mosavie M, et al
    Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
    J Antimicrob Chemother. 2022;77:1753-1761.
    PubMed     Abstract available


  204. LUQUE-PAZ D, Bennis Y, Jaubert P, Dubee V, et al
    Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    J Antimicrob Chemother. 2022;77:1787-1789.
    PubMed    


  205. OUESLATI S, Raymond J, Croue M, Carvahlo L, et al
    MDR bacterial isolates in environmental samples from Kinshasa, Democratic Republic of the Congo.
    J Antimicrob Chemother. 2022;77:1785-1787.
    PubMed    


  206. IWUJI C, Pillay D, Shamu P, Murire M, et al
    A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.
    J Antimicrob Chemother. 2022 May 17. pii: 6586623. doi: 10.1093.
    PubMed     Abstract available


  207. BRAZIER A, Merriam S, Halpern D
    BSAC Vanguard Series: Behavioural science and antimicrobial resistance.
    J Antimicrob Chemother. 2022 May 16. pii: 6586211. doi: 10.1093.
    PubMed     Abstract available


  208. GOLPARIAN D, Kittiyaowamarn R, Paopang P, Sangprasert P, et al
    Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
    J Antimicrob Chemother. 2022 May 11. pii: 6583486. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  209. ZHANG X, Shi S, Yao Z, Zheng X, et al
    Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574685. doi: 10.1093.
    PubMed     Abstract available


  210. BARENG OT, Moyo S, Zahralban-Steele M, Maruapula D, et al
    HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    J Antimicrob Chemother. 2022;77:1385-1395.
    PubMed     Abstract available


  211. GUPTA A, Landman D, Quale J
    Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:1282-1285.
    PubMed     Abstract available


  212. PACIOS O, Fernandez-Garcia L, Bleriot I, Blasco L, et al
    Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-beta-naphthylamide (PabetaN): co-resistance to antimicrobials.
    J Antimicrob Chemother. 2022;77:1272-1281.
    PubMed     Abstract available


  213. YANG D, Heederik DJJ, Scherpenisse P, Van Gompel L, et al
    Antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) abundance in animal faeces, meat, production environments and human faeces in Europe.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573562. doi: 10.1093.
    PubMed     Abstract available


  214. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    PubMed     Abstract available


  215. LIU C, Dong N, Zeng Y, Lu J, et al
    Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571571. doi: 10.1093.
    PubMed     Abstract available


  216. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    PubMed     Abstract available


  217. ENER B, Ergin C, Gulmez D, Agca H, et al
    Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571734. doi: 10.1093.
    PubMed     Abstract available


  218. SCHINK AK, Hanke D, Semmler T, Brombach J, et al
    Novel multiresistance-mediating integrative and conjugative elements carrying unusual antimicrobial resistance genes in Mannheimia haemolytica and Pasteurella multocida.
    J Antimicrob Chemother. 2022 Apr 18. pii: 6569420. doi: 10.1093.
    PubMed    


  219. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    PubMed     Abstract available


  220. FUCHS F, Becerra-Aparicio F, Xanthopoulou K, Seifert H, et al
    In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    J Antimicrob Chemother. 2022 Apr 12. pii: 6566767. doi: 10.1093.
    PubMed     Abstract available


  221. HARMER CJ, Lebreton F, Stam J, McGann PT, et al
    Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance.
    J Antimicrob Chemother. 2022 Apr 11. pii: 6566059. doi: 10.1093.
    PubMed     Abstract available


  222. CHARANI E
    BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance.
    J Antimicrob Chemother. 2022 Apr 6. pii: 6564004. doi: 10.1093.
    PubMed     Abstract available


  223. CHAIBEN V, Yamada CH, Telles JP, de Andrade AP, et al
    A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562691. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  224. SUN Z, Lan Y, Liang S, Wang J, et al
    Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.
    J Antimicrob Chemother. 2022;77:1119-1124.
    PubMed     Abstract available


  225. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    PubMed     Abstract available


  226. CHEUNG PK, Shahid A, Dong W, Lepik KJ, et al
    Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
    J Antimicrob Chemother. 2022;77:979-988.
    PubMed     Abstract available


  227. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    PubMed    


  228. AMBROSE SJ, Hamidian M, Hall RM
    Extensively resistant Acinetobacter baumannii isolate RCH52 carries several resistance genes derived from an IncC plasmid.
    J Antimicrob Chemother. 2022;77:930-933.
    PubMed     Abstract available


  229. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of the novel optrA-carrying pseudo-compound transposon Tn7363 and an Inc18 plasmid carrying cfr(D) in Vagococcus lutrae.
    J Antimicrob Chemother. 2022;77:921-925.
    PubMed     Abstract available


  230. MARGOT N, Vanderveen L, Naik V, Ram R, et al
    Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study.
    J Antimicrob Chemother. 2022;77:989-995.
    PubMed     Abstract available


  231. GOFF D
    BSAC Vanguard Series: The future of antibiotic stewardship-managing access and excess.
    J Antimicrob Chemother. 2022;77:863-864.
    PubMed     Abstract available


  232. TICKNER JA, Bradshaw CS, Murray GL, Whiley DM, et al
    Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    J Antimicrob Chemother. 2022 Mar 30. pii: 6555777. doi: 10.1093.
    PubMed     Abstract available


  233. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    PubMed    


  234. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    PubMed     Abstract available


  235. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    PubMed     Abstract available


  236. CREMANNS M, Lange F, Gatermann SG, Pfennigwerth N, et al
    Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Mar 10. pii: 6546017. doi: 10.1093.
    PubMed     Abstract available


  237. NEVILLE LF, Shalit I, Warn PA, Rendell JT, et al
    Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    J Antimicrob Chemother. 2022 Mar 1. pii: 6539950. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  238. DUBEY V, Devnath K, Gupta VK, Kalyan G, et al
    Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.
    J Antimicrob Chemother. 2022 Feb 24. pii: 6535191. doi: 10.1093.
    PubMed     Abstract available


  239. YAN L, Yu F, Liang J, Cheng Y, et al
    Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China.
    J Antimicrob Chemother. 2022;77:727-734.
    PubMed     Abstract available


  240. ELIAS P, Barraud O, El Hamel C, Chainier D, et al
    Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections.
    J Antimicrob Chemother. 2022;77:767-770.
    PubMed     Abstract available


  241. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    PubMed     Abstract available


  242. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    PubMed    


  243. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    PubMed     Abstract available


  244. HACHIYA A, Kubota M, Shigemi U, Ode H, et al
    Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitors.
    J Antimicrob Chemother. 2022;77:574-577.
    PubMed     Abstract available


  245. LOPEZ-DIAZ M, Ellaby N, Turton J, Woodford N, et al
    NDM-1 carbapenemase resistance gene vehicles emergent on distinct plasmid backbones from the IncL/M family.
    J Antimicrob Chemother. 2022;77:620-624.
    PubMed     Abstract available


  246. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    PubMed     Abstract available


  247. KHOUJA T, Mitsantisuk K, Tadrous M, Suda KJ, et al
    Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 Feb 18. pii: 6530407. doi: 10.1093.
    PubMed     Abstract available


  248. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    PubMed     Abstract available


  249. DARLOW CA, Farrington N, Johnson A, McEntee L, et al
    Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6529341. doi: 10.1093.
    PubMed     Abstract available


  250. SHI S, Zhang X, Yao Z, Xu M, et al
    Synergistic effect of the novel beta-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528648. doi: 10.1093.
    PubMed     Abstract available


  251. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    PubMed     Abstract available


  252. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    PubMed     Abstract available


  253. MENDELSON M
    BSAC Vanguard Series: Inequality and antibiotic resistance.
    J Antimicrob Chemother. 2022;77:277-278.
    PubMed     Abstract available


  254. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  255. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2022;77:400-408.
    PubMed     Abstract available


  256. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  257. HENERICO S, Mikasi SG, Kalluvya SE, Brauner JM, et al
    Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania.
    J Antimicrob Chemother. 2022;77:483-491.
    PubMed     Abstract available


  258. DUAN Y, Liu S, Gao Y, Zhang P, et al
    Macrolides mediate transcriptional activation of the msr(E)-mph(E) operon through histone-like nucleoid-structuring protein (HNS) and cAMP receptor protein (CRP).
    J Antimicrob Chemother. 2022;77:391-399.
    PubMed     Abstract available


  259. CASALONE E, Vignolini T, Braconi L, Gardini L, et al
    Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    J Antimicrob Chemother. 2022;77:413-424.
    PubMed     Abstract available


  260. EL BOUZIDI K, Datir RP, Kwaghe V, Roy S, et al
    Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.
    J Antimicrob Chemother. 2022;77:474-482.
    PubMed     Abstract available


  261. LE HINGRAT Q, Collin G, Damond F, Peytavin G, et al
    In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
    J Antimicrob Chemother. 2022;77:409-412.
    PubMed     Abstract available


  262. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    PubMed     Abstract available


  263. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    PubMed     Abstract available


    January 2022
  264. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    PubMed    


  265. SHINTANI M, Suzuki H, Nojiri H, Suzuki M, et al
    Precise classification of antimicrobial resistance-associated IncP-2 megaplasmids for molecular epidemiological studies on Pseudomonas species.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515317. doi: 10.1093.
    PubMed    


  266. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    PubMed     Abstract available


  267. YANG D, Heederik DJJ, Mevius DJ, Scherpenisse P, et al
    Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries.
    J Antimicrob Chemother. 2022 Jan 21. pii: 6513516. doi: 10.1093.
    PubMed     Abstract available


  268. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    PubMed     Abstract available


  269. MADER R, Bourely C, Amat JP, Broens EM, et al
    Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach.
    J Antimicrob Chemother. 2022 Jan 12. pii: 6504034. doi: 10.1093.
    PubMed     Abstract available


  270. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    PubMed     Abstract available


  271. WELLS D
    BSAC Vanguard Series: The future role of laboratories in relation to antimicrobial resistance.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503859. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  272. ESSACK S
    BSAC Vanguard Series: From treatment options to precision medicine: the future of 'omics-based' antibiotic resistance surveillance data.
    J Antimicrob Chemother. 2021;77:5-6.
    PubMed     Abstract available


  273. OSTERHOLM MT
    BSAC Vanguard Series: the future of ADVOCACY on AMR.
    J Antimicrob Chemother. 2021;77:1-2.
    PubMed     Abstract available


  274. BERMAN D, Neale R
    BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    J Antimicrob Chemother. 2021;77:3-4.
    PubMed     Abstract available


  275. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    PubMed     Abstract available


  276. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    PubMed     Abstract available


  277. HUANG SW, Shen MC, Wang WH, Li WY, et al
    High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.
    J Antimicrob Chemother. 2021;77:185-195.
    PubMed     Abstract available


  278. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    PubMed     Abstract available


  279. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    PubMed     Abstract available


  280. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    PubMed     Abstract available


  281. HOWARD-ANDERSON J, Davis M, Page AM, Bower CW, et al
    Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464149. doi: 10.1093.
    PubMed     Abstract available


  282. TELLO M, Oporto B, Lavin JL, Ocejo M, et al
    Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring blaNDM-1 in an IncC plasmid.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6462046. doi: 10.1093.
    PubMed    


  283. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    PubMed     Abstract available


  284. LIU G, Thomsen LE, Olsen JE
    Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459601. doi: 10.1093.
    PubMed     Abstract available


  285. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    PubMed     Abstract available


  286. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    PubMed     Abstract available


  287. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    PubMed     Abstract available


  288. SUN S, Wang Q, Jin L, Guo Y, et al
    Identification of multiple transfer units and novel subtypes of tmexCD-toprJ gene clusters in clinical carbapenem-resistant Enterobacter cloacae and Klebsiella oxytoca.
    J Antimicrob Chemother. 2021 Dec 7. pii: 6454463. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  289. VOSS A
    BSAC Vanguard Series: The future of infection prevention and control: how COVID is already transforming our approach to antimicrobial resistance.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440021. doi: 10.1093.
    PubMed     Abstract available


  290. DAVIES DS
    BSAC Vanguard Series: Are we finally finding our voice on antimicrobial resistance?
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440039. doi: 10.1093.
    PubMed     Abstract available


  291. HAYWARD G, Turner P
    BSAC Vanguard Series: Antimicrobial resistance and the future of diagnostic testing.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440024. doi: 10.1093.
    PubMed     Abstract available


  292. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    PubMed     Abstract available


  293. BOUZA E
    The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  294. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427458. doi: 10.1093.
    PubMed     Abstract available


  295. MONTEJANO R, Dominguez-Dominguez L, de Miguel R, Rial-Crestelo D, et al
    Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
    J Antimicrob Chemother. 2021;76:3263-3271.
    PubMed     Abstract available


  296. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


  297. DELORY T, Le Bel J, Lariven S, Peiffer-Smadja N, et al
    Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423107. doi: 10.1093.
    PubMed     Abstract available


  298. LIEPA R, Mann R, Osman M, Hamze M, et al
    Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain.
    J Antimicrob Chemother. 2021 Nov 6. pii: 6422573. doi: 10.1093.
    PubMed     Abstract available


  299. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    PubMed    


    October 2021
  300. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


  301. GUILLOTEAU H, Pradalier C, Roman VL, Bellanger X, et al
    Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay.
    J Antimicrob Chemother. 2021 Oct 21. pii: 6407543. doi: 10.1093.
    PubMed     Abstract available


  302. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Oct 20. pii: 6403927. doi: 10.1093.
    PubMed     Abstract available


  303. NDASHIMYE E, Li Y, Reyes PS, Avino M, et al
    High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
    J Antimicrob Chemother. 2021;76:2965-2974.
    PubMed     Abstract available


  304. XIE YN, Zhu FX, Zhong YT, Chen YT, et al
    Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    J Antimicrob Chemother. 2021;76:2975-2982.
    PubMed     Abstract available


  305. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    PubMed    


  306. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    PubMed     Abstract available


  307. DE LAZZARI E, Gonzalez-Cordon A, Inciarte A, Ugarte A, et al
    Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort.
    J Antimicrob Chemother. 2021;76:2988-2992.
    PubMed     Abstract available


  308. CHARPENTIER C, Storto A, Soulie C, Ferre VM, et al
    Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
    J Antimicrob Chemother. 2021;76:2983-2987.
    PubMed     Abstract available


  309. HE YZ, Kuang X, Long TF, Li G, et al
    Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    J Antimicrob Chemother. 2021 Oct 6. pii: 6382243. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  310. BARRAUD O, Guichard E, Chainier D, Postil D, et al
    Integrons, a predictive biomarker for antibiotic resistance in acute sepsis: the IRIS study.
    J Antimicrob Chemother. 2021 Sep 24. pii: 6374797. doi: 10.1093.
    PubMed     Abstract available


  311. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    PubMed     Abstract available


  312. AMBROSE SJ, Hall RM
    Origin of the dfrA44 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371308. doi: 10.1093.
    PubMed    


  313. BANGALEE A, Hans L, Steegen K
    Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    J Antimicrob Chemother. 2021;76:2659-2665.
    PubMed     Abstract available


  314. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  315. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  316. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  317. GILL CM, Abdelraouf K, Oota M, Nakamura R, et al
    Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
    J Antimicrob Chemother. 2021;76:2615-2621.
    PubMed     Abstract available


  318. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    PubMed    


  319. TOMCZYK S, Taylor A, Brown A, de Kraker MEA, et al
    Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362680. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  320. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  321. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  322. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    PubMed     Abstract available


  323. ZHU Y, Yang Q, Schwarz S, Yang W, et al
    Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA.
    J Antimicrob Chemother. 2021 Aug 18. pii: 6354200. doi: 10.1093.
    PubMed    


  324. HISCOX JA, Khoo SH, Stewart JP, Owen A, et al
    Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
    J Antimicrob Chemother. 2021;76:2230-2233.
    PubMed     Abstract available


  325. ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
    Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
    J Antimicrob Chemother. 2021;76:2394-2399.
    PubMed     Abstract available


  326. MARTIN C, Gracias S, Charpentier C, Descamps D, et al
    HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
    J Antimicrob Chemother. 2021;76:2306-2309.
    PubMed     Abstract available


  327. TAYLOR E, Bal AM, Balakrishnan I, Brown NM, et al
    A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.
    J Antimicrob Chemother. 2021;76:2428-2436.
    PubMed     Abstract available


  328. MARCELIN AG, Charpentier C, Bellecave P, Abdi B, et al
    Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
    J Antimicrob Chemother. 2021;76:2400-2406.
    PubMed     Abstract available


  329. WATERA C, Ssemwanga D, Namayanja G, Asio J, et al
    HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    J Antimicrob Chemother. 2021;76:2407-2414.
    PubMed     Abstract available


  330. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  331. WICKRAMAGE I, Spigaglia P, Sun X
    Mechanisms of antibiotic resistance of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327067. doi: 10.1093.
    PubMed     Abstract available


  332. LIU P, Hao Z, Liu M, Niu M, et al
    Genetic mutations in adaptive evolution of growth-independent vancomycin-tolerant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327451. doi: 10.1093.
    PubMed     Abstract available


  333. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  334. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.
    J Antimicrob Chemother. 2021;76:2061-2070.
    PubMed     Abstract available


  335. MILLIERE L, Bocket L, Tinez C, Robineau O, et al
    Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.
    J Antimicrob Chemother. 2021;76:2143-2147.
    PubMed     Abstract available


  336. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  337. BRENNER BG, Oliveira M, Ibanescu RI, Routy JP, et al
    Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.
    J Antimicrob Chemother. 2021;76:2137-2142.
    PubMed     Abstract available


  338. BIGGEL M, Zurfluh K, Treier A, Nuesch-Inderbinen M, et al
    Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples.
    J Antimicrob Chemother. 2021;76:2004-2011.
    PubMed     Abstract available


    June 2021
  339. AMBROSE SJ, Hall RM
    dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering.
    J Antimicrob Chemother. 2021 Jun 28. pii: 6310424. doi: 10.1093.
    PubMed     Abstract available


  340. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  341. LU HF, Tsai YC, Li LH, Lin YT, et al
    Role of AzoR, a LysR-type transcriptional regulator, in SmeVWX pump-mediated antibiotic resistance in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307154. doi: 10.1093.
    PubMed     Abstract available


  342. ZINNER SH, Alieva KN, Golikova MV, Strukova EN, et al
    Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
    J Antimicrob Chemother. 2021;76:1832-1839.
    PubMed     Abstract available


  343. HORNER C, Mushtaq S, Allen M, Longshaw C, et al
    Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
    J Antimicrob Chemother. 2021;76:1822-1831.
    PubMed     Abstract available


  344. LAUMEN JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, et al
    Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2021;76:1752-1758.
    PubMed     Abstract available


  345. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  346. JIMENEZ DE ORY S, Beltran-Pavez C, Gutierrez-Lopez M, Santos MDM, et al
    Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure.
    J Antimicrob Chemother. 2021;76:1886-1892.
    PubMed     Abstract available


  347. GISKE CG, Kahlmeter G, MacGowan A, Turnidge J, et al
    Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study.
    J Antimicrob Chemother. 2021;76:1949-1950.
    PubMed    


  348. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Erratum to: Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Jun 14. pii: 6298302. doi: 10.1093.
    PubMed    


    May 2021
  349. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  350. ABDI B, Chebbi M, Wirden M, Teyssou E, et al
    No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
    J Antimicrob Chemother. 2021;76:1553-1557.
    PubMed     Abstract available


  351. LI JZ, Stella N, Choudhary MC, Javed A, et al
    Impact of pre-existing drug resistance on risk of virological failure in South Africa.
    J Antimicrob Chemother. 2021;76:1558-1563.
    PubMed     Abstract available


  352. MERNISSI T, Bodeau S, Andre C, Zahr N, et al
    An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.
    J Antimicrob Chemother. 2021;76:1643-1646.
    PubMed    


  353. YADAV K, Garoff L, Huseby DL, Hughes D, et al
    Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2021;76:1441-1447.
    PubMed     Abstract available


  354. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  355. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  356. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  357. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  358. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  359. TRUSWELL A, Abraham R, O'Dea M, Lee ZZ, et al
    Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance.
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248215. doi: 10.1093.
    PubMed     Abstract available


  360. RAOULT D, Hadjadj L, Baron SA, Rolain JM, et al
    Role of glyphosate in the emergence of antimicrobial resistance in bacteria?
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248211. doi: 10.1093.
    PubMed     Abstract available


  361. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  362. AMBROSE SJ, Hall RM
    Identification of the dfrA4 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226985. doi: 10.1093.
    PubMed    


  363. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  364. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  365. DELAUGERRE C, Nere ML, Eymard-Duvernay S, Armero A, et al
    Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
    J Antimicrob Chemother. 2021;76:1286-1293.
    PubMed     Abstract available


  366. BROWN JA, Amstutz A, Nsakala BL, Seeburg U, et al
    Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    J Antimicrob Chemother. 2021;76:1294-1298.
    PubMed     Abstract available


  367. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  368. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  369. FELICIO MR, Silveira GGOS, Oshiro KGN, Meneguetti BT, et al
    Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2021;76:1174-1186.
    PubMed     Abstract available


  370. SEMENGUE ENJ, Armenia D, Inzaule S, Santoro MM, et al
    Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    J Antimicrob Chemother. 2021;76:1277-1285.
    PubMed     Abstract available


  371. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  372. MASHE T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, et al
    Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019.
    J Antimicrob Chemother. 2021;76:1160-1167.
    PubMed     Abstract available


  373. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  374. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  375. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  376. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  377. KRAGH KN, Gijon D, Maruri A, Antonelli A, et al
    Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
    J Antimicrob Chemother. 2021;76:1001-1009.
    PubMed     Abstract available


  378. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  379. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  380. ENGONE-ONDO JD, Mouinga-Ondeme A, Lekana-Douki SE, Diane A, et al
    High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy.
    J Antimicrob Chemother. 2021;76:1051-1056.
    PubMed     Abstract available


  381. JONES JC, Pascua PNQ, Harrington WN, Webby RJ, et al
    Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.
    J Antimicrob Chemother. 2021;76:957-960.
    PubMed     Abstract available


  382. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


    February 2021
  383. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  384. KAO SW, Liu ZH, Wu TS, Ku SW, et al
    Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    J Antimicrob Chemother. 2021;76:722-728.
    PubMed     Abstract available


  385. BUTLER DA, Rana AP, Krapp F, Patel SR, et al
    Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    J Antimicrob Chemother. 2021;76:671-679.
    PubMed     Abstract available


  386. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  387. PHAM HT, Alves BM, Yoo S, Xiao MA, et al
    Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.
    J Antimicrob Chemother. 2021;76:639-647.
    PubMed     Abstract available


  388. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


    January 2021
  389. TEMKIN E, Margalit I, Nutman A, Carmeli Y, et al
    Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  390. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  391. MACHUCA J, Recacha E, Gallego-Mesa B, Diaz-Diaz S, et al
    Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:338-344.
    PubMed     Abstract available


  392. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  393. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  394. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  395. HUA X, Moran RA, Xu Q, He J, et al
    Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2021;76:65-69.
    PubMed     Abstract available


  396. CHERNY SS, Nevo D, Baraz A, Baruch S, et al
    Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling.
    J Antimicrob Chemother. 2021;76:239-248.
    PubMed     Abstract available


  397. SALADINI F, Giammarino F, Hosseini BA, Giannini A, et al
    In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
    J Antimicrob Chemother. 2021;76:130-134.
    PubMed     Abstract available


  398. WENK BM, Mbunkah HA, Nsanwe NN, Mbu ET, et al
    Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
    J Antimicrob Chemother. 2021;76:124-129.
    PubMed     Abstract available


    December 2020
  399. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


    November 2020
  400. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  401. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed     Abstract available


  402. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed     Abstract available


  403. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  404. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  405. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  406. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  407. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  408. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  409. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  410. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  411. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  412. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


  413. LIM JM, Singh SR, Duong MC, Legido-Quigley H, et al
    Impact of national interventions to promote responsible antibiotic use: a systematic review.
    J Antimicrob Chemother. 2020;75:14-29.
    PubMed     Abstract available


  414. VISSEAUX B, Assoumou L, Mahjoub N, Grude M, et al
    Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
    J Antimicrob Chemother. 2020;75:183-193.
    PubMed     Abstract available


  415. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  416. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  417. TZOU PL, Rhee SY, Descamps D, Clutter DS, et al
    Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    J Antimicrob Chemother. 2020;75:170-182.
    PubMed     Abstract available


  418. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  419. RODRIGUEZ-VILLODRES A, Gil-Marques ML, Alvarez-Marin R, Bonnin RA, et al
    Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.
    J Antimicrob Chemother. 2020;75:77-85.
    PubMed     Abstract available


  420. MODICA S, Redi D, Gagliardini R, Giombini E, et al
    Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
    J Antimicrob Chemother. 2020;75:194-199.
    PubMed     Abstract available


  421. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  422. DORTET L, Broda A, Bernabeu S, Glupczynski Y, et al
    Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
    J Antimicrob Chemother. 2020;75:110-116.
    PubMed     Abstract available


  423. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  424. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  425. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  426. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  427. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  428. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  429. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  430. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  431. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


  432. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  433. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  434. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.